This newest twist during the Lykos Therapeutics saga threatens A serious overhaul of the business’s tactic and way, with Musk ally and billionaire investor Antonio Gracias showing to desire to get the company again toward its nonprofit drug enhancement roots and a far more Doblinite philosophy.In several respects, the for-profit copyright industr